Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
Saari, H., Turunen, T., Lõhmus, A., Turunen, M., Jalasvuori, M., Butcher, S. J., Ylä-Herttuala, S., Viitala, T., Cerullo, V., Siljander, P. R. M., & Yliperttula, M. (2020). Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery. Journal of Extracellular Vesicles, 9(1), Article 1747206. https://doi.org/10.1080/20013078.2020.1747206
Julkaistu sarjassa
Journal of Extracellular VesiclesTekijät
Päivämäärä
2020Oppiaine
Biologisten vuorovaikutusten huippututkimusyksikköSolu- ja molekyylibiologiaCentre of Excellence in Biological Interactions ResearchCell and Molecular BiologyTekijänoikeudet
© 2020 The Authors
Extracellular vesicles (EVs) have been showcased as auspicious candidates for delivering therapeutic cargo, including oncolytic viruses for cancer treatment. Delivery of oncolytic viruses in EVs could provide considerable advantages, hiding the viruses from the immune system and providing alternative entry pathways into cancer cells. Here we describe the formation and viral cargo of EVs secreted by cancer cells infected with an oncolytic adenovirus (IEVs, infected cell-derived EVs) as a function of time after infection. IEVs were secreted already before the lytic release of virions and their structure resembled normally secreted EVs, suggesting that they were not just apoptotic fragments of infected cells. IEVs were able to carry the viral genome and induce infection in other cancer cells. As such, the role of EVs in the life cycle of adenoviruses may be an important part of a successful infection and may also be harnessed for cancer- and gene therapy.
Julkaisija
Taylor & FrancisISSN Hae Julkaisufoorumista
2001-3078Asiasanat
Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/35257624
Metadata
Näytä kaikki kuvailutiedotKokoelmat
Rahoittaja(t)
Suomen AkatemiaRahoitusohjelmat(t)
Akatemiatutkijan tutkimuskulut, SALisätietoja rahoituksesta
This work was supported by the Academy of Finland [287089, 292275, 268376, 314985, 328601, 315409]; Alfred Kordelinin Säätiö [160385]; Emil Aaltosen Säätiö [170223]; Suomen Kulttuurirahasto [2018].Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
Garofalo, M.; Saari, H.; Somersalo, P.; Crescenti, D.; Kuryk, L.; Aksela, L.; Capasso, C.; Madetoja, M.; Koskinen, Katariina; Oksanen, T.; Mäkitie, A.; Jalasvuori, Matti; Cerullo, V.; Ciana, P.; Yliperttula, M. (Elsevier BV, 2018)Standard of care for cancer is commonly a combination of surgery with radiotherapy or chemoradiotherapy. However, in some advanced cancer patients this approach might still remaininefficient and may cause many side effects, ... -
Extracellular vesicles and high‐density lipoproteins : Exercise and oestrogen‐responsive small RNA carriers
Karvinen, Sira; Korhonen, Tia‐Marje; Sievänen, Tero; Karppinen, Jari E.; Juppi, Hanna‐Kaarina; Jakoaho, Veera; Kujala, Urho M.; Laukkanen, Jari A.; Lehti, Maarit; Laakkonen, Eija K. (Wiley, 2023)Decreased systemic oestrogen levels (i.e., menopause) affect metabolic health. However, the detailed mechanisms underlying this process remain unclear. Both oestrogens and exercise have been shown to improve metabolic ... -
Musculoskeletal Responses to Exercise plus Nutrition in Men with Prostate Cancer on Androgen Deprivation : A 12-month RCT
Via, Jack Dalla; Owen, Patrick J.; Daly, Robin M.; Mundell, Niamh L.; Livingston, Patricia M.; Rantalainen, Timo; Foulkes, Stephen J.; Millar, Jeremy L.; Murphy, Declan G.; Fraser, Steve F. (Lippincott Williams & Wilkins, 2021)Purpose Androgen deprivation therapy (ADT) for prostate cancer (PCa) has multiple adverse effects on musculoskeletal health. This 12-month randomised controlled trial aimed to assess the effects of multi-component exercise ... -
Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
Via, Jack Dalla; Daly, Robin M.; Owen, Patrick J.; Mundell, Niamh L.; Rantalainen, Timo; Fraser, Steve F. (Elsevier Inc., 2019)Androgen deprivation therapy (ADT) improves survival in men with advanced prostate cancer (PCa), but has been associated with compromised skeletal health and increased fracture risk. However, limited previous research has ... -
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
Saarenheimo, Jatta; Eigeliene, Natalja; Andersen, Heidi; Tiirola, Marja; Jekunen, Antti (Frontiers Media SA, 2019)Targeted therapies have allowed for an individualized treatment approach in non-small-cell lung cancer (NSCLC). The initial therapeutic decisions and success of targeted therapy depend on genetic identification of personal ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.